Background: Somatic alterations of cyclin-dependent kinase 2 (CDK2)-cyclin E complex have been shown to contribute to breast cancer (BC) development and progression. This study aimed to explore the effects of single nucleotide polymorphisms (SNPs) in CDK2 and CCNE1 (a gene encoding G1/S specific cyclin E1 protein, formerly called cyclin E) on BC risk, progression and survival in a Chinese Han population. Methodology/Principal Findings:We herein genotyped 6 haplotype-tagging SNPs (htSNPs) of CCNE1 and 2 htSNPs of CDK2 in 1207 BC cases and 1207 age-matched controls among Chinese Han women, and then reconstructed haplotype blocks according to our genotyping data and linkage disequilibrium status of these htSNPs. For CCNE1, the minor allele hom...
Studies investigating possible associations between cytochrome P4501B1 ( CYP1B1 ) polymorphisms and ...
Previous studies of families with multiple cases of breast cancer have indicated that a frameshift a...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
BACKGROUND: Somatic alterations of cyclin-dependent kinase 2 (CDK2)-cyclin E complex have been shown...
<div><h3>Background</h3><p>Somatic alterations of cyclin-dependent kinase 2 (CDK2)-cyclin E complex ...
The CCNB1 and CDK1 genes encode the proteins of CyclinB1 and CDK1 respectively, which interact with ...
The CCNB1 and CDK1 genes encode the proteins of CyclinB1 and CDK1 respectively, which interact with ...
The CCNB1 and CDK1 genes encode the proteins of CyclinB1 and CDK1 respectively, which interact with ...
<div><p>The <i>CCNB1</i> and <i>CDK1</i> genes encode the proteins of CyclinB1 and <i>CDK1</i> respe...
This study aims to investigate whether the germline variants in CDH1 and CTNNB1 would affect breast ...
Introduction: Centrosome aberrations and cell-cycle deregulation have important implications for ova...
<div><p>This study aims to investigate whether the germline variants in <i>CDH1</i> and <i>CTNNB1</i...
Cyclin D1 (CCND1), an intracellular cell-cycle regulatory protein with checkpoint function, can prom...
Previous studies of families with multiple cases of breast cancer have indicated that a frameshift a...
Previous studies of families with multiple cases of breast cancer have indicated that a frameshift a...
Studies investigating possible associations between cytochrome P4501B1 ( CYP1B1 ) polymorphisms and ...
Previous studies of families with multiple cases of breast cancer have indicated that a frameshift a...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...
BACKGROUND: Somatic alterations of cyclin-dependent kinase 2 (CDK2)-cyclin E complex have been shown...
<div><h3>Background</h3><p>Somatic alterations of cyclin-dependent kinase 2 (CDK2)-cyclin E complex ...
The CCNB1 and CDK1 genes encode the proteins of CyclinB1 and CDK1 respectively, which interact with ...
The CCNB1 and CDK1 genes encode the proteins of CyclinB1 and CDK1 respectively, which interact with ...
The CCNB1 and CDK1 genes encode the proteins of CyclinB1 and CDK1 respectively, which interact with ...
<div><p>The <i>CCNB1</i> and <i>CDK1</i> genes encode the proteins of CyclinB1 and <i>CDK1</i> respe...
This study aims to investigate whether the germline variants in CDH1 and CTNNB1 would affect breast ...
Introduction: Centrosome aberrations and cell-cycle deregulation have important implications for ova...
<div><p>This study aims to investigate whether the germline variants in <i>CDH1</i> and <i>CTNNB1</i...
Cyclin D1 (CCND1), an intracellular cell-cycle regulatory protein with checkpoint function, can prom...
Previous studies of families with multiple cases of breast cancer have indicated that a frameshift a...
Previous studies of families with multiple cases of breast cancer have indicated that a frameshift a...
Studies investigating possible associations between cytochrome P4501B1 ( CYP1B1 ) polymorphisms and ...
Previous studies of families with multiple cases of breast cancer have indicated that a frameshift a...
Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK1...